Real-time enrollment status for this refractory non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:54 PM UTC
| NCT Number | NCT04545762 |
| Recruiting Status | Recruiting |
| Condition | Refractory Non-Hodgkin Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | C. Babis Andreadis |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT04545762 is currently recruiting participants. This clinical trial study for refractory non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by C. Babis Andreadis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04545762 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04545762 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.